title: The Na+/H+ exchange inhibitor HOE642 prevents stress-induced epithelial barrier dysfunction.
abstract: Recently, evidence has been obtained that the Na+/H+ exchange (NHE) inhibitor HOE642 may stabilize endothelial and epithelial barrier function in vivo. However, the underlying mechanisms are not known. Therefore, we studied the influence of HOE642 on the barrier function of the epithelial cell line CaCo2. The phorbolester phorbol 12-myristate 13-acetate (PMA) was used to induce hyperpermeability of the epithelial layer which was indirectly determined by measuring the transepithelial electrical resistance (TER). Confocal laser scan microscopy (LSM) served to analyze the intracellular localization of adherens and tight junction molecules. In five independent experiments we found that HOE642 increased TER in non-treated CaCo2 cells (control: 350 +/- 28 Omega/cm2; HOE642: 444 +/- 53 Omega/cm2) and prevented PMA-induced barrier dysfunction (PMA: 33 +/- 12 Omega/cm2; PMA plus HOE642: 496 +/- 47 Omega/cm2). LSM showed that HOE642 prevented the PMA-induced disassociation of the zonula adherens molecule beta-catenin from the cell membrane and the decreased expression of the zonula occludens molecule ZO-1. From our data we conclude that HOE642 may prevent stress-induced epithelial dysfunction by stabilization of cell membrane-associated junction molecules.
authors.affiliation: Klinik für Thorax-, Herz- und thorakale Gefässchirurgie, Johann Wolfgang Goethe-Universität, Frankfurt am Main D-60590, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Nowak
authors.forename: Roman
authors.initials: R
authors.lastname: Blaheta
authors.forename: Alina
authors.initials: A
authors.lastname: Schuller
authors.forename: Jindrich
authors.initials: J
authors.lastname: Cinatl
authors.forename: Gerhard
authors.initials: G
authors.lastname: Wimmer-Greinecker
authors.forename: Anton
authors.initials: A
authors.lastname: Moritz
authors.forename: Martin
authors.initials: M
authors.lastname: Scholz
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D018938:Caco-2 Cells; D002273:Carcinogens; D003598:Cytoskeletal Proteins / Q000378:metabolism; D017097:Electric Impedance; D004594:Electrophysiology; D004847:Epithelial Cells / Q000378:metabolism; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism*; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D018613:Microscopy, Confocal; D008856:Microscopy, Fluorescence; D010539:Permeability; D017923:Sodium-Hydrogen Exchangers / Q000502:physiology; D013450:Sulfones / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate; D019108:Tight Junctions; D013997:Time Factors; D015534:Trans-Activators / Q000378:metabolism; D051176:beta Catenin
chemical_list: D000889:Anti-Arrhythmia Agents; C495270:CTNNB1 protein, human; D002273:Carcinogens; D003598:Cytoskeletal Proteins; D006146:Guanidines; D017923:Sodium-Hydrogen Exchangers; D013450:Sulfones; D015534:Trans-Activators; D051176:beta Catenin; C093373:cariporide; D013755:Tetradecanoylphorbol Acetate